Literature DB >> 20059725

Minimal acute rejection in pediatric lung transplantation--does it matter?

Christian Benden1, Albert Faro, Sarah Worley, Susana Arrigain, Paul Aurora, Manfred Ballmann, Debra Boyer, Carol Conrad, Irmgard Eichler, Okan Elidemir, Samuel Goldfarb, George B Mallory, Peter J Mogayzel, Daiva Parakininkas, Melinda Solomon, Gary Visner, Stuart C Sweet, Lara A Danziger-Isakov.   

Abstract

In adult lung transplantation, a single minimal AR episode is a significant predictor of BOS independent of other factors. However, the significance of single minimal AR episodes in children is unknown. A retrospective, multi-center analysis was performed to determine whether isolated single AR episodes are associated with an increased BOS risk in children. Risk factors for BOS, death, or re-transplantation, and a combined outcome of BOS, death, or re-transplantation were assessed. Original data included 577 patients (<21 yr of age). A total of 383 subjects were eligible for the study. Fifteen percent of patients developed BOS, and 13% of patients either died or underwent re-transplant within one-yr post-transplant. In the multivariable survival model for time to BOS, there was no significant risk to developing BOS after a single minimal AR (A1) episode (HR 1.7, 95% CI 0.64-4.8; p=0.28). Even after a second minimal AR episode, no significant risk for BOS was appreciated. However, a single episode of mild AR (A2) was associated with twice the risk of BOS within one-yr post-transplant. In this select cohort, a single minimal AR episode was not associated with an increased risk for BOS within one yr following lung transplantation, in contrast to previous reports in adults. Copyright (c) 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2010        PMID: 20059725      PMCID: PMC2888626          DOI: 10.1111/j.1399-3046.2009.01268.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  17 in total

1.  Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.

Authors:  T J Kroshus; V R Kshettry; K Savik; R John; M I Hertz; R M Bolman
Journal:  J Thorac Cardiovasc Surg       Date:  1997-08       Impact factor: 5.209

2.  Reliability for grading acute rejection and airway inflammation after lung transplantation.

Authors:  Murali M Chakinala; Jon Ritter; Brian F Gage; Aviva A Aloush; Ramsey H Hachem; John P Lynch; G Alexander Patterson; Elbert P Trulock
Journal:  J Heart Lung Transplant       Date:  2005-06       Impact factor: 10.247

3.  The significance of a single episode of minimal acute rejection after lung transplantation.

Authors:  Ramsey R Hachem; Anthony P Khalifah; Murali M Chakinala; Roger D Yusen; Aviva A Aloush; Thalachallour Mohanakumar; G Alexander Patterson; Elbert P Trulock; Michael J Walter
Journal:  Transplantation       Date:  2005-11-27       Impact factor: 4.939

4.  Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome.

Authors:  Anthony P Khalifah; Ramsey R Hachem; Murali M Chakinala; Roger D Yusen; Aviva Aloush; G Alexander Patterson; Thalachallour Mohanakumar; Elbert P Trulock; Michael J Walter
Journal:  Am J Transplant       Date:  2005-08       Impact factor: 8.086

5.  Lung transplantation and life extension in children with cystic fibrosis.

Authors:  P Aurora; B Whitehead; A Wade; J Bowyer; P Whitmore; P G Rees; V T Tsang; M J Elliott; M de Leval
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

6.  Risk factors for the development of obliterative bronchiolitis after lung transplantation.

Authors:  R E Girgis; I Tu; G J Berry; H Reichenspurner; V G Valentine; J V Conte; A Ting; I Johnstone; J Miller; R C Robbins; B A Reitz; J Theodore
Journal:  J Heart Lung Transplant       Date:  1996-12       Impact factor: 10.247

Review 7.  Bronchiolitis obliterans syndrome: pathogenesis and management.

Authors:  Ramsey R Hachem; Elbert P Trulock
Journal:  Semin Thorac Cardiovasc Surg       Date:  2004

Review 8.  Post-transplant bronchiolitis obliterans.

Authors:  A Boehler; M Estenne
Journal:  Eur Respir J       Date:  2003-12       Impact factor: 16.671

9.  Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis.

Authors:  Peter M Hopkins; Christina L Aboyoun; Prashant N Chhajed; Monique A Malouf; Marshall L Plit; Stephen P Rainer; Allan R Glanville
Journal:  Am J Respir Crit Care Med       Date:  2004-08-05       Impact factor: 21.405

10.  True survival benefit of lung transplantation for cystic fibrosis patients: the Zurich experience.

Authors:  Markus Hofer; Christian Benden; Ilhan Inci; Christoph Schmid; Sarosh Irani; Rudolf Speich; Walter Weder; Annette Boehler
Journal:  J Heart Lung Transplant       Date:  2009-04       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.